Aardvark Therapeutics (AARD)
5.72
+0.59 (11.50%)
Upcoming Events
Latest Headlines
Form 4 Aardvark Therapeutics, For: Sep 10 Filed by: Sun Nelson
September 11, 2026 8:14 PM - SEC Filing
Form 144 Aardvark Therapeutics, Filed by: Sun Nelson
September 11, 2026 4:51 PM - SEC Filing
Form 144 Aardvark Therapeutics, Filed by: Sun Nelson
September 10, 2026 5:18 PM - SEC Filing
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Aardvark Therapeutics, Inc. (AARD) to Contact Law Firm
September 10, 2026 3:57 PM - PR NewsWire
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar L
September 10, 2026 8:22 AM - StreetInsider
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): G
September 1, 2026 8:25 AM - StreetInsider
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL);
August 31, 2026 8:45 AM - StreetInsider
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Of
August 27, 2026 8:51 AM - StreetInsider
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Chi Jeffrey
August 21, 2026 7:49 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Graf Susan E
August 21, 2026 7:47 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Baynes Roy D.
August 21, 2026 7:46 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Tong Victor Edward Jr
August 21, 2026 7:45 PM - SEC Filing
Form 8-K Aardvark Therapeutics, For: Aug 14
August 17, 2026 4:10 PM - SEC Filing
Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
August 11, 2026 5:24 PM - StreetInsider
Form 10-Q Aardvark Therapeutics, For: Jun 30
August 11, 2026 5:10 PM - SEC Filing
Form 8-K Aardvark Therapeutics, For: Aug 11
August 11, 2026 5:05 PM - SEC Filing
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 11, 2026 4:53 PM - Globe NewsWire
Form ARS Aardvark Therapeutics, For: Dec 31
July 10, 2026 4:12 PM - SEC Filing
Form DEF 14A Aardvark Therapeutics, For: Aug 14
July 10, 2026 4:06 PM - SEC Filing
Form PRE 14A Aardvark Therapeutics, For: Aug 14
June 29, 2026 4:06 PM - SEC Filing
Full Article List
